Created to tap the potential of agriculture to generate value through the creation of blockbuster pharmaceuticals: cheaper, faster, and with less risk
Launched in December of 1996, Phytomedics is a privately owned Company that operates from its corporate headquarters in Jamesburg, NJ. Most of the Company's R&D takes place at the Biotech Center at Rutgers University, under the leadership of Dr. Ilya Raskin, a Company co-founder. Phytomedics signed a broad research and licensing agreement with Rutgers University that allows the Company to exclusively license its core technologies and products. This affiliation with Rutgers enables the Company to operate at a low expense rate while using state-of-the-art laboratories and greenhouses and accessing the diverse expertise available in a leading university. Phytomedics is funded by a broad international consortium of life science investors including Swiss based inventages venture capital GmbH (life ventures by Nestle), U.S. based Burrill & Company, Israeli based Polar Investments Ltd and Biotech M.A.H. Plant Genomic Fund (jointly run by Makhteshim Agan Industries and Hazera Genetics), and Nestir SA, the venture arm of the giant South American agro-industrial conglomerate, the Arlei group.